$CORZ

Weiss Eric Stanton purchased $98K of CORZ

Weiss Eric Stanton purchased 6,000 shares of Core Scientific, Inc./tx (CORZ) at $16.33 on 2026-09-15.

Original reporting
SEC EDGAR · Weiss Eric Stanton
Published Sep 17, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The purchase is a routine insider transaction with limited trading relevance.

02

Market read

Minor insider purchase; unlikely to affect market perception or price.

03

What to watch

Potential upcoming capital raise or strategic move not disclosed.

Relevance 4/10Novelty 3/10Timing: post-market filing

Background

Form 4 filings disclose insider transactions; director purchases are monitored for signals.

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

Director Eric Stanton bought 6,000 shares of Core Scientific for $97,980, increasing his stake to 265,262 shares.

Expected impact

minimal impact, no immediate price change expected

Evidence & confidence

Purchase size is modest relative to market cap and typical trading volume.

Market effects

None; Core Scientific operates in data center services, no sector-wide impact.

None; US-listed microcap with limited broader market relevance.

None

Counterpoint

Insider buying could signal confidence, but size is too small to be meaningful.

Key entities

  • Core Scientific, Inc.

    US-listed data center services provider (NASDAQ: CORZ).

  • Eric Stanton

    Director of Core Scientific.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

CoreWeave, AI landlord stocks sink to lowest levels in more than a year as the price of insuring CoreWeave's debt doubles

Neocloud stocks, including CoreWeave (CRWV), IREN, Core Scientific (CORZ), and Cipher Mining (CIFR), have fallen over 40% since July. CoreWeave's credit default swap costs have doubled, signaling increased default risk. Microsoft (MSFT) has gained nearly as much. Nebius (NBIS) is an exception, performing better due to lower debt. Elon Musk noted lenders are restricting funding for AI data center-dependent companies.

$BTC-USDMed

AI Pivot Fails to Slow Bitcoin Mining Competition as Hashrate Surges

Bitcoin's network hashrate hit a seven-month high of 1 zettahash per second, despite large miners shifting to AI. Mining difficulty rose 5.92% in October, with another 5.16% increase expected. Public miners' hashrate fell 23% while AI revenue rose 52% in Q2 2026, displacing about $1.5 billion in equipment. Companies like Core Scientific and IREN reduced Bitcoin production, while MARA and Riot absorbed displaced network share.

$APLDMed

Applied Digital Sinks 4% as Rotation Out of Debt-Funded AI Builders Extends; TeraWulf Dips 3%, Core Scientific Retreats 2%

Applied Digital (APLD) shares fell 4% to $19.59, extending a downturn in leveraged AI data center developers. TeraWulf (WULF) and Core Scientific (CORZ) also declined. JPMorgan cut APLD's bond rating to Neutral, citing debt concerns. APLD reported strong Q1 revenue growth but carries significant debt. Management maintains confidence in its balance sheet and funding plans.

$CORZHigh

KBW keeps Core Scientific at outperform, says AMD’s 1.9 GW reservation is overlooked

KBW reiterated its Outperform rating and $28 price target on Core Scientific (CORZ), citing overlooked 1.9 GW of AMD reservation capacity. The firm values existing leases at $15.54 per share, with a blended NOI/EV yield of 8.3%. KBW attended Core Scientific's investor day and noted AMD's option for additional capacity. CORZ closed at $15.43 on Tuesday, implying 81.5% upside to the target.